Evolent Health Depreciation & Amortization Growth & History (EVH)
Evolent Health's depreciation and amortization was $115.9M for fiscal 2025.
View full Evolent Health company overviewEvolent Health annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $115.9M | −$2.5M | −2.13% |
| 2024 | 2024-12-31 | $118.4M | −$5.0M | −4.09% |
| 2023 | 2023-12-31 | $123.4M | $56.2M | +83.67% |
| 2022 | 2022-12-31 | $67.2M | $7.2M | +11.92% |
| 2021 | 2021-12-31 | $60.0M | −$1.4M | −2.34% |
| 2020 | 2020-12-31 | $61.5M | $562,000 | +0.92% |
| 2019 | 2019-12-31 | $60.9M | $16.4M | +36.84% |
| 2018 | 2018-12-31 | $44.5M | $12.1M | +37.53% |
| 2017 | 2017-12-31 | $32.4M | $15.1M | +87.92% |
| 2016 | 2016-12-31 | $17.2M | $10.1M | +140.36% |
| 2015 | 2015-12-31 | $7.2M | $7.2M | — |
| 2014 | 2014-12-31 | $0 | −$1.2M | — |
| 2013 | 2013-12-31 | $1.2M | — | — |
Evolent Health quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $21.6M | −$1.6M | −6.81% |
| Q1 2026 | 2026-03-31 | $21.6M | −$2.5M | −10.40% |
| Q4 2025 | 2025-12-31 | $45.0M | — | — |
| Q3 2025 | 2025-09-30 | $23.6M | −$6.1M | −20.49% |
| Q2 2025 | 2025-06-30 | $23.1M | −$6.7M | −22.53% |
| Q1 2025 | 2025-03-31 | $24.1M | −$5.4M | −18.46% |
| Q3 2024 | 2024-09-30 | $29.7M | −$2.7M | −8.34% |
| Q2 2024 | 2024-06-30 | $29.9M | −$2.3M | −7.05% |
| Q1 2024 | 2024-03-31 | $29.5M | $228,000 | +0.78% |
| Q3 2023 | 2023-09-30 | $32.4M | $15.2M | +88.44% |
| Q2 2023 | 2023-06-30 | $32.1M | $17.0M | +112.64% |
| Q1 2023 | 2023-03-31 | $29.3M | $14.2M | +93.80% |
| Q3 2022 | 2022-09-30 | $17.2M | $2.3M | +15.73% |
| Q2 2022 | 2022-06-30 | $15.1M | $196,000 | +1.31% |
| Q1 2022 | 2022-03-31 | $15.1M | −$241,000 | −1.57% |
| Q3 2021 | 2021-09-30 | $14.9M | $325,000 | +2.24% |
| Q2 2021 | 2021-06-30 | $14.9M | −$702,000 | −4.49% |
| Q1 2021 | 2021-03-31 | $15.3M | −$791,000 | −4.90% |
| Q3 2020 | 2020-09-30 | $14.5M | −$874,000 | −5.67% |
| Q2 2020 | 2020-06-30 | $15.6M | $326,000 | +2.13% |
| Q1 2020 | 2020-03-31 | $16.1M | $1.9M | +13.12% |
| Q3 2019 | 2019-09-30 | $15.4M | $5.1M | +48.84% |
| Q2 2019 | 2019-06-30 | $15.3M | $5.3M | +52.40% |
| Q1 2019 | 2019-03-31 | $14.3M | $4.8M | +50.23% |
| Q3 2018 | 2018-09-30 | $10.4M | $2.6M | +34.15% |
| Q2 2018 | 2018-06-30 | $10.0M | $3.1M | +45.34% |
| Q1 2018 | 2018-03-31 | $9.5M | $2.9M | +43.55% |
| Q3 2017 | 2017-09-30 | $7.7M | $4.0M | +106.01% |
| Q2 2017 | 2017-06-30 | $6.9M | $3.3M | +91.14% |
| Q1 2017 | 2017-03-31 | $6.6M | $3.2M | +96.23% |
| Q3 2016 | 2016-09-30 | $3.7M | $690,000 | +22.58% |
| Q2 2016 | 2016-06-30 | $3.6M | $2.6M | +267.07% |
| Q1 2016 | 2016-03-31 | $3.4M | $3.4M | — |
| Q3 2015 | 2015-09-30 | $3.1M | $3.1M | — |
| Q2 2015 | 2015-06-30 | $984,000 | $984,000 | — |
| Q1 2015 | 2015-03-31 | $0 | — | — |
| Q3 2014 | 2014-09-30 | $0 | — | — |
| Q2 2014 | 2014-06-30 | $0 | — | — |
Evolent Health depreciation and amortization trends
Over the last five fiscal years, Evolent Health's depreciation and amortization increased from $61.5M to $115.9M, a change of $54.4M. The latest reported quarter, Q2 2026, shows $21.6M.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Evolent Health source filings ↗